20/30 INDEFLATOR -REF 1000184 WPL2122268-01 (2019-03-01)
FDA Device Recall #Z-0921-2022 — Class II — March 11, 2022
Recall Summary
| Recall Number | Z-0921-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 11, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Abbott Vascular |
| Location | Temecula, CA |
| Product Type | Devices |
| Quantity | 17 lots |
Product Description
20/30 INDEFLATOR -REF 1000184 WPL2122268-01 (2019-03-01)
Reason for Recall
Due to an increase in complaint trend for leaks and intermittent/loose connections.
Distribution Pattern
U.S Nationwide Distribution.: AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, SC, TN, TX, VA, WA, and WI. O.U.S.: United Arab Emirates, France, Pakistan, Argentina, United Kingdom, Portugal, Australia, Greece, R¿union, Belgium, Guam, Romania, Brazil, Indonesia, Russian Federation, Bahamas, Israel, Saudi Arabia, Canada, India, Singapore, Switzerland, Italy, Slovakia, Chile, Jamaica, Thailand, China, Japan, Taiwan Republic of China, Colombia, Korea (South), Costa Rica, Luxembourg, Uruguay, Czech Republic, Mexico, Vietnam, Germany, Netherlands, South Africa, Dominican Republic, New Zealand, Spain, and Panama
Lot / Code Information
Part Numbers: 1000184 Device Identifier-GTIN: 08717648013591 Lot Numbers: 60309678 60320071 60337162 60311336 60320899 60337166 60311338 60331726 60311337 60311339 60331727 60317539 60315914 60334491 60318209 60317535 60334492
Other Recalls from Abbott Vascular
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0116-2023 | Class II | Product/Part: MitraClip NTR Clip Delivery Syste... | Sep 8, 2022 |
| Z-0115-2023 | Class II | Product/Part: MitraClip XTR Clip Delivery Syste... | Sep 8, 2022 |
| Z-0117-2023 | Class II | Product/Part: MitraClip G4 CDS NT REPAIR-MR Cli... | Sep 8, 2022 |
| Z-1095-2022 | Class I | Dragonfly OpStar Imaging Catheter, REF 1014651/... | Mar 30, 2022 |
| Z-0924-2022 | Class II | INDEFLATOR Plus 30 - REF 1000183 WPL2122277-01 ... | Mar 11, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.